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ABSTRACT
Turmeric (Curcuma longa) is widely used as herbal medicine, not exception by pregnant women. Turmeric consumption by expec -
tant mothers requires standard dose, because of its antiangiogenic effect could be harmful on placentation process and embryonic de -
velopment. This experiment was undertaken to determine the effect of different concentrations of turmeric decoctum to the expres -
sion of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) and Angiopoietin 1 (Ang-1) on the 48-hours-old chicken embryo.
In this study, turmeric were extracted using decoction method to mimic the common method as adopted by people. The turmeric de -
coctum were freeze dried into a powder form, and was used in preparing the stock solution for 200 ppm (P1), 300 ppm (P2), and 400
ppm (P3) as experimental treatments. The control group (P0) received 2% DMSO without turmeric decoctum. These were adminis -
tered on the yolk sack of 16 hours incubation of fertile chicken egg by number of 200 µL. After 48 hours incubation, the expression
of VEGFR-2 and Ang-1 on the chicken embryo was counted by ImageJ software. The results revealed that there is no significant eff-
ffect of turmeric decoctum to the expression of VEGFR-2 and Ang-1. This suggested that turmeric decoctum was safe up to 400 ppm
on chicken embryo.
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Turmeric (Curcuma longa) is often used as herbal
medicine (hereafter referred to as “Jamu”) for it is be-
lieved to have  many benefits,  e.g.  anti-inflammatory,
antioxidant,  antimicrobial  and anticancer [1].  Several
descriptive  studies  revealed  that  the  consumption  of
Jamu  by  expectant  mothers  is  still  common  [2,  3].
There are several types of Jamu which contain turmeric
that  commonly  consumed  by  pregnant  woman  to
strengthen  their  pregnancy.  Those  variants  can  be
found in the form of pre-packed consumer products al-
though  they  can  also  be  self-prepared  (i.e.  home-
brewed) [4]. 
Some research suggests  that  turmeric,  which cur-
cumin is the major compound, has the effect of inhibit-
ing  angiogenesis  [5].  Angiogenesis  is  the  process  of
new blood vessel formation from the pre-existing vessel
[6]. Angiogenesis plays an important role in multitude
physiological  processes,  including  the  placentation
process and embryonic development [7]. There are sev-
eral molecules that regulate the angiogenesis process,
two of which are VEGFR-2 and Angiopoietin-1 (Ang-
1) [7, 8, 9].
VEGFR-2  is  an  early  marker  of  endothelial  cells
and  hematopoietic  precursor  cells  during  embryonic
blood vessel development, as a response to the increase
of  VEGF  quantity–especially  VEGF-A,  generated  by
mesenchymal  cells  around  it.  The  binding  between
VEGF-A with VEGFR-2 initiates the formation of en-
dothelial  cells  which  in  turn  will  form the  primary
blood vessels [10]. VEGFR-2 show tyrosine kinase ac-
tivity 10 fold higher than VEGFR-1 [11]. Another im-
portant molecule, Ang-1, play an important role in the
development and maturation of embryo’s blood vessels
[12].  Abnormalities  during  angiogenesis  process  can
lead to embryonic development disorder and even mor-
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tality [7].
Chicken embryo has been cited as a fit model for
studying angiogenesis [13]. The purpose of this study
was to determine the effect of different concentrations
of turmeric decoctum to VEGFR-2 and Ang-1 expres-
sion on chicken embryos.
Extraction method
Fresh  turmeric  rhizome  were  purchased  from
Materia  Medica  Batu,  Health  Departement  of  East
Java. 500 g turmeric were cut down into small pieces,
added to 2500 mL distilled water then boiled for 15
minutes to obtain aqueous extract of the turmeric. The
solution  were  allowed  to  cool,  filtered  using  muslin
cloth and store at -200C. The solution was freeze dried
into powder samples  and stored at  40C.  Thin Layer
Chromatography  (TLC),  a  qualitative  phytochemical
test, was used to detect the presence of phenolic and
terpenoid compound by using standard procedures.
Preparing experimental treatment
As  much  as  500  mg  of  the  turmeric  decoctum
powder  were  dissolved  in  DMSO  2%  as  the  stock
solution.  This  solution  were  used  for  preparing  the
concentration of 200 ppm (P1), 300 ppm (P2), and 400
ppm (P3). The control group (P0) received DMSO 2%
without turmeric decoctum.
Administration of  turmeric decoctum to the chicken
embryo
The  protocol  applied  for  this  experiment  was
approved  by  the  ethics  committee  of  Faculty  of
Medicine,  Universitas  Brawijaya,  Malang.  Fertile
chicken eggs were purchased from avian breeder group
“Lestari Sejahtera”- Modopuro - Mojosari - Mojokerto
– East Java. The eggs were stored at 15°C for less than
1 week and incubated at 37.5°-39°C up to 16 hours
(reach  to  the  stage  3+  according  to  the  criteria
Hamburger and Hamilton [14]) in horizontal position
with respect to the long axis [15].
Treatments  were  done  in  ovo  by  injection  using
disposable syringe 1 mL (23 gauge) at the beginning of
the primitive streak (stage 3+ according to the criteria
Hamburger and Hamilton [14]). 48 fertile chicken egg
were divided into 4 group (n=12) as control group (P0)
and treatment group (P1, P2, and P3). Fertile chicken
eggs were prepared  for injection by cleaning the blunt
end of egg with alcohol swab. A small hole was made
in the blunt end of egg by blood lancet, then 200 µL of
turmeric decoctum was injected into the center of egg
yolks.  After  injection,  holes  were  closed  with  vinyl
tape, and the eggs were turned 180° and reincubated
until  stage  12+  according  to  the  criteria  Hamburger
and Hamilton (48 hours incubation) [14, 15].
Collecting the sample
Each egg was cracked carefully and the content was
pour  into  a  petri  dish.  The  frame  from  thick  filter
paper (external dimension 1.4  ×  1.4 cm with internal
window 1 cm2) was laid down on the surface of the
yolk with the placing of embryo was central within the
window.  The  outside  of  the  frame  was  cut  around
when the frame getting wet. The frame was lifted up
gently with forcep then washed in a dish with normal
saline. The frame contain the embryo was transferred
into paraformaldehyde 4% and stored at 40°C[16].
Whole  mount  immunohistochemistry  and  data
collection
Whole  mount  immunohistochemistry  was
performed  to  determine  the  expression  of  VEGFR-2
and Ang-1 by using specific antibody anti  VEGFR-2
(A-3): sc-6251 and Ang-1 (C-19): sc-6320 (Santa Cruz
Biotechnology®).  DAB was  used  in  colour  develop-
ment  process.  Embryo  were  observed  using  stereo
microscope  with  20  times  magnification.  Two
dimension  (2D)  picture  was  taken  by  using  camera
DSLR Panasonic DMC-GH2 fixed to the microscope.
The expression of VEGFR-2 and Ang-1 were shown as
mean  of  2D  picture  colour  density  intraembryonic
region that is counted  by software ImageJ [17]. Higher
density  of  the  colour  means  higher  expression  of
VEGFR-2 or Ang-1 on chicken embryo. The data were
analyzed statistically by One way ANOVA at p = 0.05
using SPSS Statistic 21.
Phytochemical detection
TLC, as a qualitative test,  detected the presence of
curcuminoid  molecule  on  the  turmeric  decoctum.
However, terpenoid molecule could not be detected.
Turmeric decoctum effect to expression of VEGFR-2
Expression  of  intraembryonic  VEGFR-2  were
shown  as  brown  colour  in  Figure  1.  Turmeric  de-
coctum effect to expression of VEGFR-2 were just as
shown in Figure 3A. It shown there were variation ex-
pression of VEGFR-2 among experimental group. They
were  expected as  body  phyisiological response  to the
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Figure 1. Expression of VEGFR-2 in each experimental group.-
Expression of VEGFR-2 were shown as brown colour
intraembryonic (black arrow). Higher density of the
colour means embryo expressed more VEGFR-2. Red
arrow shows extraembryonic vascular.
Figure 2. Expression of Ang-1 in each experimental group. Ex-
pression of Ang-1 were shown as brown colour in-
traembryonic  (black  arrow).  Higher  density  of  the
colour means embryo expressed more Ang-1. Red ar-
row shows extraembryonic vascular.
stressor.  That response involves multiple cellular  sig-
naling pathways and molecular mechanisms to produce
cytoprotective proteins including growth factors [25].
Recent  study suggested  that  body responded vary  in
the expression of VEGFR-2 to anticipate the negative
effect that colud be caused by administration of various
dose of turmeric decoctum.
According to statistical analysis by One way AN-
OVA, it shown that there was no significant differences
in expression of VEGFR-2 among experimental group 
(a)
(b)
Figure 3. Average number of expression of VEGFR-2 (A) and
Ang-1 (B) in each experimental group. P1 showed the
highest average of expression of either VEGFR-2 or
Ang-1. P0 = control; P1 = treated with 200 ppm of
turmeric decoctum; P2 = treated with 300 ppm of tur-
meric decoctum; P3 = treated with 400 ppm of tur-
meric decoctum.
(p = 0.099). It could be attributed to low amount and
partial solubility of the turmeric phytochemicals in wa-
ter. The property of curcumin (turmeric’s most signi-
ficant component) which is pleiotropic, by working in
multiple  mechanisms  and  regulating  many  different
target  molecules,  could  also  affect  the  expression  of
VEGFR-2. Moreover, the dose used in this study was
too low to register meaningful effects on the expression
of  VEGFR-2.  Although  many  prior  research  suggest
that turmeric, which curcumin is a major active sub-
stance, has the effect of inhibiting angiogenesis process
[5]. 
Liu  et  al.  had reported  that  turmeric  extract  has
pharmacological activity 5 fold more potent as antian-
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giogenic  than  pure  curcumin  compound  [18].  Cur-
cumin has been known to be potential in downregula-
tion of proangiogenic factors, such as VEGF[5]. Inhibi-
tion on VEGF expression can also decrease the expres-
sion of VEGFR-2, due to the presence of receptor also
determined by its ligands[8]. The study on tumor cell
in mice shown that curcumin can decrease the percent-
age of tumor cells that express VEGFR-2 up to 28.6%
[19].
Some studies proved that curcumin significanly de-
creases  HIF-1α,  HIF-1β and  creb-binding  protein
(CBP)/p300 through increasing proteosomal degrada-
tion [20,  21, 22,  23].  Moreover,  this caused decrease
the level and also activation of HIF-1 as well as disrupt
transcriptional  some growth factor molecule,  such as
VEGF and VEGFR-2 [8, 24].
Turmeric decoctum effect to expression of Ang-1
Expression of Ang-1 were shown as brown colour
intraembryonic  area  in Figure 2.  Turmeric  decoctum
effect to expression of Ang-1 was just as shown in fig-
ure 3B. According to One way ANOVA, it shown that
there  was  no  significant  differences  in  expression  of
Ang-1  among  experimental  group  (p  =  0.858).  Low
amount and partial  solubility  of  the turmeric  phyto-
chemicals in water, the pleiotropic effect of curcumin
could also affect the expression of Ang-1. The same as
effect on expression of VEGFR-2, the dose used in this
study was too low to register meaningful effects on the
expression of Ang-1.
This result disperated from prior research that sug-
gested  Ang-1 has  the  regulation process  that  similar
with  VEGFR-2  through  mechanism  by  HIF.  Some
studies  proved  that  curcumin  significantly  decreases
HIF-1α, HIF-1β and creb-binding protein (CBP)/p300
through increasing proteosomal degradation. Downreg-
ulation  of  HIF-1α,  HIF-1β,  and  CBP/p300  suppress
the activity of HIF-1 which is a transcriptional factor
for angiogenic molecules including Ang-1 [20, 21, 22,
23]. Gururaj, et al. suggest that curcumin has antian-
giogenic effect by lowering gene expression of Ang-1
and Ang-2 molecules [26].
This  result  contrast  with other  research could  be
due to differences in methods of extraction. Although
the dose used was based on previous research, in this
study turmeric was extracted through decoction meth-
ods, based on general public in consuming turmeric. It
may  caused  a  number  of  different  active  substances
that is extracted.
This  study  suggested  that  administration  of
turmeric decoctum until 400 ppm did not significantly
influence the expression of VEGFR-2 and Ang-1 on the
chicken embryo.
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